Investor Relations

Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ Capital Market.

Press Releases

Posted on Sep 23, 2016
EDEN PRAIRIE, Minn., Sept. 23, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH) today announced that on September 21, 2016, it received a letter from the Nasdaq Listing Qualifications Staff indicating that the Company did not timely demonstrate compliance with the $1.00 bid price require...

Read More

Posted on Aug 25, 2016
EDEN PRAIRIE, Minn., Aug. 25, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (NASDAQ:SSH), today announced that on August 18, 2016, the Compensation Committee of its Board of Directors, which is composed entirely of independent directors, approved four equity awards, to be effective as of August 22...

Read More

Posted on Aug 18, 2016
EDEN PRAIRIE, Minn., Aug. 18, 2016 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) announced today that its Chief Executive Officer and Chairman of the Board, John Erb, is scheduled to present at the 2016 investMNt Conference in Minneapolis, MN on August 24th at 11:45 AM CT. To access t...

Read More

Events & Presentations

Posted on Aug 24, 2016 at 11:45 AM CT
Posted on Aug 9, 2016 at 9:00 AM ET
Posted on May 26, 2016 at 3:30 AM CT